HUMAN INTERLEUKIN-2 - MOLECULAR-BIOLOGY, PHYSIOLOGY AND CLINICAL POSSIBILITIES

被引：57

作者：

MERTELSMANN, R

WELTE, K

机构：

[1] UNIV MAINZ,DEPT HEMATOL,D-6500 MAINZ,FED REP GER

[2] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021

来源：

IMMUNOBIOLOGY | 1986年 / 172卷 / 3-5期

关键词：

D O I：

10.1016/S0171-2985(86)80121-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：400 / 419

页数：20

共 107 条

[1]

ANDERSON TC, 1981, CANCER, V48, P2702, DOI 10.1002/1097-0142(19811215)48:12<2702::AID-CNCR2820481224>3.0.CO

[2]

2-L

[3]

ARYA SK, 1984, J IMMUNOL, V133, P273

[4] CLEARANCE RATES AND SYSTEMIC EFFECTS OF INTRAVENOUSLY ADMINISTERED INTERLEUKIN-2 (IL-2) CONTAINING PREPARATIONS IN HUMAN-SUBJECTS [J].

BINDON, C ;

CZERNIECKI, M ;

RUELL, P ;

EDWARDS, A ;

MCCARTHY, WH ;

HARRIS, R ;

HERSEY, P .

BRITISH JOURNAL OF CANCER, 1983, 47 (01) :123-133

[5]

BORGSTROM S, 1982, NEW ENGL J MED, V307, P1080

[6] TRANSIENT EXPRESSION OF INTERLEUKIN-2 RECEPTORS - CONSEQUENCES FOR T-CELL GROWTH [J].

CANTRELL, DA ;

SMITH, KA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1895-1911

[7] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J].

CHEEVER, MA ;

GREENBERG, PD ;

FEFER, A ;

GILLIS, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :968-980

[8]

CHEEVER MA, 1984, J BIOL RESP MODIF, V3, P113

[9]

CHEEVER MA, 1980, J IMMUNOL, V125, P711

[10] DEFECTIVE T-CELL RESPONSE TO PHA AND MITOGENIC MONOCLONAL-ANTIBODIES IN MALE-HOMOSEXUALS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS INVITRO CORRECTION BY INTERLEUKIN-2 [J].

CIOBANU, N ;

WELTE, K ;

KRUGER, G ;

VENUTA, S ;

GOLD, J ;

FELDMAN, SP ;

WANG, CY ;

KOZINER, B ;

MOORE, MAS ;

SAFAI, B ;

MERTELSMANN, R .

JOURNAL OF CLINICAL IMMUNOLOGY, 1983, 3 (04) :332-340

← 1 2 3 4 5 6 7 8 9 10 →